Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Hard sci-fi focuses on scientific accuracy, and movies like Primer and Arrival prove that this grounded approach can still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results